Interact to see
Advertisement
Advertisement
DRCVX vs RYVNX
DRCVX vs RYVNX Comparison
Open Charts DRCVX vs RYVNX
DRCVX vs RYVNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
DRCVX vs. RYVNX commentary
Jul 26, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRCVX is a Hold and RYVNX is a Hold.
FUNDAMENTALS
Fundamentals
RYVNX (11.3M) and DRCVX (11M) have equal amount of cash in the bank . RYVNX pays higher dividends than DRCVX: RYVNX (15.71) vs DRCVX (1.90). DRCVX was incepted earlier than RYVNX: DRCVX (41 years) vs RYVNX (26 years). DRCVX (3.15) is less costly to investors than RYVNX (1.89). DRCVX has a lower initial minimum investment than RYVNX: DRCVX (1000) vs RYVNX (2500). RYVNX IRA initial investment is lower compared to DRCVX: RYVNX (1000) vs DRCVX (250). DRCVX annual gain was more profitable for investors over the last year : 6.63 vs. RYVNX (-33.36). DRCVX return over 5 years is better than : 32.24 vs. RYVNX (-82.51).
| DRCVX | RYVNX | DRCVX / RYVNX | |
| Total Expense Ratio | 0.00 | 1.79 | - |
| Annual Report Gross Expense Ratio | 3.15 | 1.89 | 167% |
| Fund Existence | 41 years | 26 years | - |
| Gain YTD | 3.394 | -22.006 | -15% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | 250 | 1000 | 25% |
| Net Assets | 11M | 11.3M | 97% |
| Annual Yield % from dividends | 1.90 | 15.71 | 12% |
| Returns for 1 year | 6.63 | -33.36 | -20% |
| Returns for 3 years | 25.39 | -73.64 | -34% |
| Returns for 5 years | 32.24 | -82.51 | -39% |
| Returns for 10 years | -29.65 | -99.21 | 30% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SLVRX | 43.59 | 0.29 | +0.67% |
| Columbia Select Large Cap Value R | |||
| HFDRX | 21.32 | 0.06 | +0.28% |
| Hartford Schroders US MidCap Opps R3 | |||
| RPMGX | 98.52 | -0.16 | -0.16% |
| T. Rowe Price Mid-Cap Growth | |||
| JMNAX | 14.08 | -0.03 | -0.21% |
| JPMorgan Research Market Neutral A | |||
| MELSX | 17.57 | -0.32 | -1.79% |
| Morgan Stanley Inst EMkts Ldrs R6 | |||